Skip to main content
. 2019 Apr 12;9:262. doi: 10.3389/fonc.2019.00262

Figure 3.

Figure 3

High level of DEPDC1 mRNA predicted poor prognosis of breast cancer patients. Patients were separated into high- or low-DEPDC1 expression groups using median as the cutoff. (A) High DEPDC1 expression level was significantly associated with shorter OS time of breast cancer patients (p < 0.001). (B) Kaplan–Meier (KM) curves revealed a shorter DFS time with high DEPDC1 expression level though there was no significant difference (p > 0.05). (C,D) Association between DEPDC1 expression and overall survival ((C), p < 0.05) and Recurrence-free survival ((D), p < 0.05) was performed with the online Kaplan–Meier survival analysis (KMplot, http://kmplot.com/analysis/).